The Destination District TIF, which includes the Libertyland project, is a proposed $125 million TIF in infrastructure development for the future erection of above-ground construction.

If you have been searching for the This Is Not a Test, you are in the right place. The film lands in theaters on Friday, February 20th. This date gives audiences a chance to see the story on the big ...

Medical illustration of coccidioides, the fungus that causes Valley fever (coccidioidomycosis). Researchers at the Mayo Clinic and Arizona State University have developed a rapid test to detect Valley ...

PHOENIX — A new rapid test for Valley Fever developed in Phoenix is getting ready to go on the market and will be a game-changer for doctors in diagnosing the disease. Valley Fever is a disease that ...

The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

A cinematic obsessive with the filmic palate of a starving raccoon, Rob London will watch pretty much anything once. With a mind like a steel trap, he's an endless fount of movie and TV trivia, borne ...

Hepatitis C is a tiny virus with a significant impact. It's a small RNA virus that spreads through the blood and infects the liver. Even though today's medicines can cure it, hepatitis C remains a ...

A new rapid test could improve treatment of urinary tract infections, by identifying the most effective antibiotic for each individual patient. The test applies different antibiotics to bacteria found ...

Since Froedtert Hospital adopted the test, the mortality rate for sepsis patients has decreased by 42% and hospital length of stay has been reduced by nearly two days for patients with a suspected ...

People could learn within 15 minutes whether they are infected with hepatitis C, thanks to a rapid test developed by Northwestern University. The test will allow doctors to diagnose infections during ...

John Ferguson does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...